There are still considerable gaps in medication care, with Black enrollees having lower use than Whites
CMS says a final decision on coverage is not likely until next spring
Major changes to prescribing instructions are rare, especially so soon after approval; change could curb the drug's use
Significantly fewer adverse reactions reported by those in the cytisine group versus the varenicline group
Lisdexamfetamine found to reduce symptoms of sluggish cognitive tempo in small group of adults with ADHD
Donanemab has already received a 'breakthrough therapy' designation from the FDA
No significant differences in language development seen at age 2 years for children born to mothers with epilepsy
ADHD medications may moderate the association between externalizing symptoms and risk for suicidality in children
Less than 5 percent of prescribers account for half of all buprenorphine treatment in the country
Patients report side effects, beliefs, and knowledge about bipolar disorder are top reasons for not taking medications